Hedinger's syndrome secondary to ileal neuroendocrine tumor

Authors

  • Ana Martín García Servicio de Cardiología. Hospital Universitario de Salamanca. IBASAL-CIBER CV. Salamanca. España
  • Agustín C. Martín García Servicio de Cardiología. Hospital Universitario de Salamanca. IBASAL-CIBER CV. Salamanca. España
  • Miguel Navarro Servicio de Oncología. Hospital Universitario de Salamanca. Salamanca. España
  • Elena Díaz Peláez Servicio de Cardiología. Hospital Universitario de Salamanca. IBASAL-CIBER CV. Salamanca. España
  • Pedro L. Sánchez Servicio de Cardiología. Hospital Universitario de Salamanca. IBASAL-CIBER CV. Salamanca. España

DOI:

https://doi.org/10.37615/retic.v1n1a12

Keywords:

carcinoid, Hedinger syndrome, 3D echocardiography, tricuspid valve.

Abstract

We present a case of Hedinger syndrome or cardiomyopathy due to metastatic carcinoid tumor of special educational interest because it allows an iconographic review of the typical characteristics of valvulopathies associated with Hedinger syndrome using different imaging techniques. Hedinger syndrome in carcinoid syndrome occurs in more than half of the cases and is produced by vasoactive substances released by the carcinoid tumor that mainly affect the right heart valves (tricuspid and pulmonary) and, in up to 10% of cases, there is also damage at the level of the aortic and/or mitral valves.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of clinical oncology: Official Journal of the American Society of Clinical Oncology 2008; 26: 3.063-3.072. DOI: https://doi.org/10.1200/JCO.2007.15.4377

Lundin L, Norheim I, Landelius J, et al. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasounddetectable cardiac abnormalities. Circulation 1988; 77: 264-269. DOI: https://doi.org/10.1161/01.CIR.77.2.264

Bhattacharyya S, Toumpanakis C, Burke M, et al. Features of carcinoid heart disease identified by 2 and 3-dimensional echocardiography and cardiac MRI. Circulation Cardiovascular imaging 2010; 3: 103-111. DOI: https://doi.org/10.1161/CIRCIMAGING.109.886846

Plockinger U, Gustafsson B, Ivan D, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: echocardiography. Neuroendocrinology 2009; 90: 190-193. DOI: https://doi.org/10.1159/000225947

Luis SA, Pellikka PA. Carcinoid heart disease: Diagnosis and management. Best practice & research Clinical endocrinology & metabolism 2016; 30: 149-158. DOI: https://doi.org/10.1016/j.beem.2015.09.005

Published

2018-04-30

How to Cite

1.
Martín García A, Martín García AC, Navarro M, Díaz Peláez E, Sánchez PL. Hedinger’s syndrome secondary to ileal neuroendocrine tumor. Rev Ecocardiogr Pract Otras Tec Imag Card (RETIC) [Internet]. 2018 Apr. 30 [cited 2024 Jul. 3];1(1):51-4. Available from: https://imagenretic.org/RevEcocarPract/article/view/152